Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials . J of Skin [Internet]. 2024 Mar. 18 [cited 2026 Jan. 20];8(2):s375. Available from: https://skin.dermsquared.com/skin/article/view/2675